Tumor progression locus 2 ablation suppressed hepatocellular carcinoma development by inhibiting hepatic inflammation and steatosis in mice

BACKGROUND: Tumor progression locus 2 (TPL2), a serine-threonine kinase, functions as a critical regulator of inflammatory pathways and mediates oncogenic events. The potential role of Tpl2 in nonalcoholic fatty liver disease (NAFLD) associated hepatocellular carcinoma (HCC) development remains unkn...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xinli, Liu, Chun, Ip, Blanche C., Hu, Kang-Quan, Smith, Donald E., Greenberg, Andrew S., Wang, Xiang-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642781/
https://www.ncbi.nlm.nih.gov/pubmed/26560698
http://dx.doi.org/10.1186/s13046-015-0254-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642781/
https://www.ncbi.nlm.nih.gov/pubmed/26560698
http://dx.doi.org/10.1186/s13046-015-0254-2

Ejemplares similares